On the 21st day there was no evidence of severe polymorphonuclear infiltrate as a response to B-CAC Figure 14, as opposed to cases sutured with polyglactin 910 Figure 15 and BBS Figure 16, which respectively still represented 56 and 44% of all cases.
En el día 21° día no se evidenció infiltrados polimorfonucleares severos como respuesta al CAC-B Figura 14 a diferencia de los casos suturados con poliglactina 910 Figura 15 y la SNT Figura 16, los cuales aún representaban el 56% y 44% de los casos respectivamente.